Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the publication entitled ...
Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This ...
The conversation around supplements has fundamentally shifted in 2026, driven by a demand for data-backed efficacy and smarter delivery mechanisms. With new clinical findings on probiotic ...
The use of mailed FIT-DNA kits in community health centers significantly increases colorectal cancer screening, though follow ...
The Nuffield Department of Women's & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited ...
Background: Diabetic Nephropathy (DN) is the leading cause of End-Stage Renal Disease (ESRD) globally. This study aimed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results